QTREX QUANTUM LTD

QTEXNASDAQ

🏆 #3464 by market capEarnings Apr 1US Equity

$1.00▼ $0.04 (−4.24%)

🌙 After hours$1.00▲ 0.41%Regular close · extended-hours price shown

1h—

24h▼ 4.2%

7d▼ 6.0%

14d▲ 16.6%

30d▼ 31.8%

1y▼ 18.4%

🏦Market Cap

$47M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $0.99 – $1.02
52-Week Range: $0.28 – $3.85
Volume: $3.44B
Avg Volume: $3.10B
Shares Outstanding: 47.5M
Next Earnings: Sep 4, 2026

Fundamentals Snapshot

Annual Revenue: $3M
Last Q Revenue: $872,957
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-0.69
Dividend Yield: —

Why Investors Own QTEX

✓High-growth profile — revenue up +23.3% YoY with expanding US Equity exposure.
✓Healthy economics — 28% gross margin and 7% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$3M▲ +28.7% YoY

Gross Margin (TTM)

28.2%▲ +1.1% YoY

Operating Income (TTM)

$767,828▲ +28.7% YoY

Free Cash Flow (TTM)

$206,235▲ +28.7% YoY

About QTREX QUANTUM LTD

QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.

🦦